MedPath
PPB Approval

SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) (50 MICROGRAMS/50 MICROGRAMS)/ML

HK-67830

Prescription only Medicines

May 4, 2023

Company Information

Company Details

11/F, ONE PACIFIC PLACE, 88, QUEENSWAY, HONG KONG

Active Ingredients

elasomeran

davesomeran

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) (50 MICROGRAMS/50 MICROGRAMS)/ML - PPB 批准文号 | MedPath